Bibliographic Details
| Title: |
Can we eliminate placebo in ALS clinical trials? |
| Authors: |
Bryan WW; Department of Neurology, University of Texas Southwestern Medical School, Dallas, USA., Hoagland RJ, Murphy J, Armon C, Barohn RJ, Goodpasture JC, Miller RG, Parry GJ, Petajan JH, Ross MA, Stromatt SC |
| Corporate Authors: |
rhCNTF ALS Study Group |
| Source: |
Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases [Amyotroph Lateral Scler Other Motor Neuron Disord] 2003 Apr; Vol. 4 (1), pp. 11-5. |
| Publication Type: |
Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: |
Publisher: Martin Dunitz Country of Publication: England NLM ID: 100964775 Publication Model: Print Cited Medium: Print ISSN: 1466-0822 (Print) Linking ISSN: 14660822 NLM ISO Abbreviation: Amyotroph Lateral Scler Other Motor Neuron Disord Subsets: MEDLINE |
| Database: |
MEDLINE Ultimate |
